144 related articles for article (PubMed ID: 3125067)
1. Buserelin suppression of endogenous gonadotropin secretion in infertile women with ovarian feedback disorders given human menopausal/human chorionic gonadotropin treatment.
Weise HC; Fiedler K; Kato K
Fertil Steril; 1988 Mar; 49(3):399-403. PubMed ID: 3125067
[TBL] [Abstract][Full Text] [Related]
2. Comparison of HMG/HCG superovulation for AID with or without superactive GnRH agonist.
Gerris J; Jacquemyn Y; Desmedt E; Delbeke L; Buytaert P
Hum Reprod; 1989 Nov; 4(8):937-40. PubMed ID: 2515211
[TBL] [Abstract][Full Text] [Related]
3. The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility.
Messinis IE; Bergh T; Wide L
Fertil Steril; 1988 Jul; 50(1):31-5. PubMed ID: 3133249
[TBL] [Abstract][Full Text] [Related]
4. Preliminary report about a modified gonadotropin (human menopausal gonadotropin/human chorionic gonadotropin) treatment in infertile patients with premature luteinization.
Zimmermann R; Bohnet HG; Weise HC; Leidenberger FA
Fertil Steril; 1984 May; 41(5):714-8. PubMed ID: 6425086
[TBL] [Abstract][Full Text] [Related]
5. [Stimulation of ovarian function with gonadotropins following suppression of endogenous gonadotropin secretion by long-term infusion of the LHRH analog buserelin].
Geisthövel F; Bliefert R; Geyer H; Breckwoldt M; Sandow J
Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):240-5. PubMed ID: 3109997
[TBL] [Abstract][Full Text] [Related]
6. Endometrial inadequacy after treatment with human menopausal gonadotropin/human chorionic gonadotropin.
Reshef E; Segars JH; Hill GA; Pridham DD; Yussman MA; Wentz AC
Fertil Steril; 1990 Dec; 54(6):1012-6. PubMed ID: 2123159
[TBL] [Abstract][Full Text] [Related]
7. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG.
Smitz J; Devroey P; Braeckmans P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
Hum Reprod; 1987 May; 2(4):309-14. PubMed ID: 3114314
[TBL] [Abstract][Full Text] [Related]
8. Observations on the combination of clomiphene citrate-human menopausal gonadotropin-human chorionic gonadotropin in the management of anovulation.
Jarrell J; McInnes R; Cooke R; Arronet G
Fertil Steril; 1981 Jun; 35(6):634-7. PubMed ID: 6788606
[TBL] [Abstract][Full Text] [Related]
9. Combined gonadotropin-releasing hormone analog and exogenous gonadotropins for ovulation induction in infertile women: efficacy related to ovarian function assessment.
Fleming R; Haxton MJ; Hamilton MP; Conaghan CJ; Black WP; Yates RW; Coutts JR
Am J Obstet Gynecol; 1988 Aug; 159(2):376-81. PubMed ID: 3136650
[TBL] [Abstract][Full Text] [Related]
10. Midluteal buserelin is superior to early follicular phase buserelin in combined gonadotropin-releasing hormone analog and gonadotropin stimulation in in vitro fertilization.
Urbancsek J; Witthaus E
Fertil Steril; 1996 May; 65(5):966-71. PubMed ID: 8612858
[TBL] [Abstract][Full Text] [Related]
11. Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme.
Smith EM; Anthony FW; Gadd SC; Masson GM
BMJ; 1989 Jun; 298(6686):1483-6. PubMed ID: 2503080
[TBL] [Abstract][Full Text] [Related]
12. Endocrine profiles and luteal function during GnRH-analogue/HMG therapy.
Braendle W; Lindner C; Lichtenberg V; Goepel E; Bettendorf G
Hum Reprod; 1989 Nov; 4(8 Suppl):121-6. PubMed ID: 2533217
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of infertile women with hypothalamic primary and secondary protracted amenorrhoea using gonadotrophin releasing hormone analogue and human menopausal gonadotrophin.
Aboulghar MA; Mansour RT; Serour GI; Ramzy AM
Hum Reprod; 1990 Jul; 5(5):557-60. PubMed ID: 2118543
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of long-term unexplained infertility with gonadotropin-releasing hormone agonist analogue and human menopausal gonadotropin.
Aboulghar MA; Mansour RT; Serour GI
Acta Obstet Gynecol Scand; 1990; 69(4):313-5. PubMed ID: 2123068
[TBL] [Abstract][Full Text] [Related]
15. Short-term utilization of a gonadotropin-releasing hormone agonist (buserelin) for induction of ovulation in an in vitro fertilization program.
Loumaye E; de Cooman S; Anoma M; Psalti I; Depreester S; Schmit M; Thomas K
Ann N Y Acad Sci; 1988; 541():96-102. PubMed ID: 3143299
[TBL] [Abstract][Full Text] [Related]
16. Short-term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization.
Macnamee MC; Howles CM; Edwards RG; Taylor PJ; Elder KT
Fertil Steril; 1989 Aug; 52(2):264-9. PubMed ID: 2502441
[TBL] [Abstract][Full Text] [Related]
17. Use of LHRH agonists in the treatment of anovulation in women with polycystic ovary syndrome.
Franks S; Sagle M; Mason HD; Kiddy D
Horm Res; 1987; 28(2-4):164-8. PubMed ID: 3136067
[TBL] [Abstract][Full Text] [Related]
18. Is continuation of a gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hyperstimulation syndrome?
Wada I; Matson PL; Horne G; Buck P; Lieberman BA
Hum Reprod; 1992 Sep; 7(8):1090-3. PubMed ID: 1400932
[TBL] [Abstract][Full Text] [Related]
19. Human prolactin release induced by follicle stimulating hormone, luteinizing hormone and human chorionic gonadotrophin.
Crosignani PG; Maini MC; Negri E; Ragni G
Hum Reprod; 1991 Sep; 6(8):1070-3. PubMed ID: 1806563
[TBL] [Abstract][Full Text] [Related]
20. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
Yuen BH; Sy L; Cannon W
Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
